Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,655 total articles
Snowflake (SNOW) has pulled back from its 52-week highs but still trades at premium multiples. With a $61.6B market cap, 30% reported revenue growth, and clear AI positioning, the stock offers a tactical long opportunity for investors willing to accept valuation and legal risk. This trade idea lays out entry, stop, targets, catalysts, and the scena…
Nvidia remains dominant in AI hardware, but the stock's multiple and recent technical drift suggest the market is pricing perfection. With P/E in the mid-30s, price-to-sales above 20, and bearish momentum indicators, this trade idea sells a controlled short at current levels with a $145 target and a $195 stop over a mid-term (45 trading days) horiz…
Uranium Royalty Corp. (UROY) offers investors a way to participate in higher uranium prices through a growing royalty portfolio and selective physical holdings. At a market cap of roughly $504.6M and a share price near $3.65, UROY is a leveraged, lower-capex play on the sector. This note lays out a mid-term (45 trading days) swing trade: entry $3.6…
Elbit Systems (ESLT) is the primary Israeli drone and defense-systems supplier benefiting directly from the recent Iran strikes and elevated regional tensions. With a $25.2 billion backlog, fresh contract wins totaling roughly $663 million announced in recent months, and bullish technical momentum, we upgrade ESLT to a buy for a long-term trade. El…
CVR Partners (UAN) is trading below its 52-week high after a distribution payment and a volatile open, leaving a $119.54 stock that yields ~9.4% and trades at an EV/EBITDA of about 8.7. Recent supply-risk chatter out of the Middle East has pushed ammonia/UAN price expectations higher; combine that with CVR's cash-generation (free cash flow ~$98.8M)…
Arista is capturing outsized demand from AI data-center upgrades. Recent quarter beat, raised guidance, a $5.4B deferred backlog, and strong free cash flow argue for a long exposure. Valuation is rich but not irrational given growth; position size and a strict stop are essential.
Peoples Financial Services (PFIS) looks oversold on momentum but fundamentally intact: low-teens return on equity, manageable debt, steady dividend growth and a P/B around 1.0 argue against an immediate downgrade. This trade targets a rebound to prior highs while protecting downside with a pragmatic stop.
Immatics is trading near a financing-induced floor after a December 2025 $10 underwritten offering and is showing multiple positive clinical readouts across its TCR-T and TCER pipelines. This trade idea treats today's price as a de-risked entry into a high-upside clinical-stage oncology story: conservative near-term upside to low double-digits and …
Positive cardiopulmonary results from the DELIVER trial and the initiation of the Phase 3 HARMONIA study for z-basivarsen (DYNE-101) meaningfully de-risk Dyne's clinical story. With shares trading near $17 and market cap around $2.8B, the setup favors a disciplined long swing trade that captures further validation and potential re-rating as late-st…
Microsoft is under pressure from headline volatility and sector rotation, and that pullback creates a defined-risk buying opportunity. This trade idea lays out a concrete entry at $360, a stop at $336 and a target at $420 over a long-term horizon (180 trading days). The thesis leans on Azure's steady revenue engine, expanding AI services, strong fr…
Tilray's move into global beverages via the BrewDog asset purchases meaningfully boosts revenue and expands distribution, taking total annualized revenue toward ~$1.2B. Fundamentals and valuation (market cap near $0.8B, P/S ~1, P/B ~0.53) argue the stock is cheap on many metrics, but negative margins, persistent free cash flow losses, and weak tech…
Red Cat (RCAT) sits squarely in the crosshairs of renewed defense spending and the Pentagon's Drone Dominance Program. The catalog of USV and tactical drone platforms, recent contract momentum, and heavy short interest create a setup for an asymmetric long. This is a tactical, high-risk long intended to capture contract awards, order cadence, and p…
Sea Limited plunged after Q4 commentary emphasized margin compression and softer Garena bookings despite beats. That sell-off has pushed technicals into oversold territory and trimmed valuation expectations versus the stock's recent highs. This trade idea takes a disciplined long stance: enter after the post-earnings weakness, use a tight structura…
Seneca Foods (SENEA) pulled back modestly this week but still trades at attractive valuation ratios versus its cash generation. With $168m of free cash flow, a sub-8x EV/EBITDA multiple and a current price near $136, a disciplined long swing (45 trading days) offers a defined risk, upside to $150 and a favorable risk-reward if margins remain intact…
Marvell just delivered a clean quarter and bullish guidance that materially re-rates its AI infrastructure exposure. The stock is trading above its moving averages with bullish momentum. This trade idea lays out an entry at $90.00, a stop at $78.00 and a primary target of $140.00 over a long-term horizon (180 trading days), with clear catalysts and…
Nvidia's product and software moat — GPUs, networking, and an expanding software stack — still commands premium multiples. After a corrective pullback into the $170s and ahead of GTC 2026, the risk-reward favors a calibrated long: entry $180.00, target $215.00, stop $160.00. The bull case leans on high free cash flow, low leverage, and structural d…
Copper fundamentals are tilting toward a long, structural deficit driven by electrification and AI infrastructure. Global X Copper Miners ETF (COPX) offers leveraged exposure to miners' operating and pricing leverage while providing a better risk/reward than holding the metal outright. Enter near $78.14, stop at $72.00, target $95.00 over a long-te…
Workiva (WK) has pulled back toward its recent range after a strong 2025 growth run. Revenue momentum, improving profitability and solid free cash flow support a tactical long here. We outline an entry at $63.00, stop at $56.00 and a $85.00 target over a 180-trading-day horizon.
Smith & Wesson (SWBI) has ripped to a 52-week high but carries weak recent sales momentum, thin profitability, an upcoming ex-dividend, and an overbought technical setup. This trade idea advocates a tactical short for a mean-reversion move back toward the $12 area over the next 10 trading days, with strict risk controls.
Carlisle Companies combines resilient cash generation, shareholder-friendly capital allocation and exposure to a construction market that is beginning to re-accelerate. The stock is trading well below its 52-week high and shows valuation upside if revenues and margins recover alongside a cyclical pickup in commercial roofing and insulation demand. …
<p>Palantir’s sell-off from the $200 area has created a tactical long opportunity. Strong top-line momentum (reported ~70% Q4 growth), an expanding deal pipeline ($8.6B remaining deal value, +91% YoY), improving technicals and light short-covering combine to favor a measured long. That said, valuation is rich and this is a high-risk trade — the pla…
Berkshire Hathaway's new-era management has restarted disciplined buybacks after a 19-month pause under Warren Buffett. At roughly $491, the stock offers an asymmetric setup: attractive valuation metrics (P/E ~16, P/B ~1.5), ongoing FCF generation (~$19.3B), and a multihundred-billion-dollar cash war chest that can be deployed opportunistically. I'…
Best Buy (BBY) offers a compelling long-term income opportunity: a 5.7% yield, solid free cash flow of $1.51B, and conservative leverage. With EV/EBITDA at 5.5 and P/FCF ~9.2, the stock looks inexpensive for a retailer that continues to expand services and vendor support. This trade targets dividend capture and upside to $82 over a 180-trading-day …
Novo-Nordisk has been beaten down alongside the GLP-1 complex. At $38.80 the stock offers a $170.9B market cap, a P/E of 11.1 and a 3.19% yield. Technicals show oversold conditions; a pragmatic long with a $50 target over 180 trading days balances upside with defined risk.
Abbott (ABT) has had a rough patch in diagnostics and a product-quality hiccup, but the balance sheet, cash generation ($7.4B free cash flow), and valuation metrics leave room for 20%+ upside over the next 6 months if management stabilizes operations and integration of Exact Sciences goes as planned. This trade plan targets entry at $110.00, a $135…
